A Study to Assess Cardiovascular Phenotype Driven Genomic Research

Overview

About this study

The purpose of this study is create a biorepository of patients/families where there is a clustering of a cardiovascular disease (CVD) phenotype with suspected genetic etiology, in order to conduct gene discovery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient with early onset coronary heart disease (CHD)/lipid disorders/other cardiovascular disease (CVD) with suspected/known genetic etiology referred from a clinical provider or found from screening for other research studies.
  • Relatives of a patient with a CVD phenotype with suspected/known genetic etiology.

Exclusion Criteria:

  • None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Iftikhar Kullo, M.D.

Open for enrollment

Contact information:

Alexandra Miller

(507) 284-5467

Miller.Alexandra@mayo.edu

More information

Publications

Publications are currently not available